https://www.selleckchem.com/products/ly333531.html
Women and caregivers will be blinded to the allocations. Food diaries, continuous glucose monitoring, and anthropometry will measure dietary compliance, glucose levels, and weight changes. Women will receive standard antenatal GDM management (insulin/metformin) according to NICE guidelines. The secondary endpoints include caesarean section rates, LGA, and maternal postnatal glucose concentrations.BACKGROUND Primary resistance to immunotherapy can be observed in approximately 40-65% of the stage IV melanoma patients treated with immune
Curtir
Comentario
Compartilhar
